AVITA Medical IncRCEL
Price$11.73

Outlook & Key Dates

Estimates, guidance, catalysts, and upcoming events

Analyst Estimates Learn more →
Analyst Coverage
2analysts covering
Consensus: PositiveAs of 18 Aug 2026
FY Revenue (est.)
$118.2Mnext fiscal year
As of 18 Aug 2026
FY EPS (est.)
-$1.45next fiscal year
As of 18 Aug 2026
Monitoring Framework
Key Performance Indicators
Net Revenue Quarterly19.3MTarget: 80000000 to 85000000
Gross Profit Margin Quarterly81.7%Target: Sustained >80% with product mix shift
Operating Expenses Quarterly24.5MTarget: Continued reduction and cost discipline
Watch Items
  • Cash Runway and Debt CovenantsTrigger: Cash balance falling below $5 million minimum covenantAction: Draw down remaining $10 million under Perceptive credit facility or seek additional capital
  • RECELL GO Commercial AdoptionTrigger: Slower than expected clinician transition to RECELL GOAction: Increase sales force training and targeted marketing in U.S. burn and trauma centers
Sign in / Sign up to read more

Research as of 19 Jun 2026

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.